Alnylam (NASDAQ: ALNY) EVP receives new options and RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ALNYLAM PHARMACEUTICALS, INC. executive Bryan Supran, EVP, CLO and Secretary, reported equity awards consisting of stock options and restricted stock units. He received stock options for 3,381 shares at an exercise price of $0.00 per share, and a grant of 1,539 shares of common stock represented by restricted stock units.
The RSUs vest over three years, with one third vesting on each of the first, second and third anniversaries of the grant date, conditioned on continued service. The stock options vest 25% on the first anniversary of the grant date, with the remainder vesting in equal quarterly installments until the fourth anniversary, also subject to continuous service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
SUPRAN BRYAN
Role
EVP, CLO and Secretary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 3,381 | $0.00 | -- |
| Grant/Award | Common Stock | 1,539 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 3,381 shares (Direct);
Common Stock — 14,565 shares (Direct)
Footnotes (1)
- These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date. The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.
FAQ
What insider transactions did ALNY executive Bryan Supran report on this Form 4 for ALNY?
Bryan Supran reported acquiring stock options for 3,381 shares and 1,539 shares of common stock via restricted stock units. Both awards were granted at no cash cost and are subject to multi-year vesting tied to his continued service with Alnylam.
How many stock options were granted to ALNY executive Bryan Supran and how do they vest?
He was granted stock options for 3,381 shares of Alnylam common stock. Twenty-five percent vests on the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments until the fourth anniversary, subject to continued employment.
What is the size and structure of the restricted stock unit grant to ALNY’s Bryan Supran?
Bryan Supran received 1,539 restricted stock units, each representing one share of Alnylam common stock. The RSUs vest over three years, with one third vesting on each of the first, second and third anniversaries of the grant date, contingent on continuous service.
Did Bryan Supran buy or sell ALNY common stock on the open market in this Form 4?
The filing reflects equity awards, not open-market trades. Supran acquired stock options and restricted stock units at a price of $0.00 per share as compensation, with vesting over time based on his continued service with Alnylam Pharmaceuticals.
Are the equity awards to ALNY executive Bryan Supran directly owned and what ownership type is reported?
The reported stock options and restricted stock units are listed as directly owned by Bryan Supran. The ownership code is shown as direct, with no footnotes indicating that another entity, such as a trust or LLC, holds voting or investment authority over these awards.